Browse treatments

…s in treating relapsed/refractory hematologic malignancies, and CAR-T cell therapy is being avidly pursued for treatment of solid tumors. However,…

…ell lung cancer (NSCLC) and associated with lack of response to checkpoint blockade immunotherapy. Cell therapies using tumor-infiltrating lymphocytes (TILs) hav…